APA (7th ed.) Citation

AC, G., RJ, L., W, L., X, Z., SAR, K., FH, M., . . . SB, W. (2023). Chemical Shift MRI Monitoring of Chemoembolization Delivery for Hepatocellular Carcinoma: Multicenter Feasibility of Initial Clinical Translation. Radiology. Imaging cancer, 5(3), e220019. https://doi.org/10.1148/rycan.220019

Chicago Style (17th ed.) Citation

AC, Gordon, et al. "Chemical Shift MRI Monitoring of Chemoembolization Delivery for Hepatocellular Carcinoma: Multicenter Feasibility of Initial Clinical Translation." Radiology. Imaging Cancer 5, no. 3 (2023): e220019. https://doi.org/10.1148/rycan.220019.

MLA (9th ed.) Citation

AC, Gordon, et al. "Chemical Shift MRI Monitoring of Chemoembolization Delivery for Hepatocellular Carcinoma: Multicenter Feasibility of Initial Clinical Translation." Radiology. Imaging Cancer, vol. 5, no. 3, 2023, p. e220019, https://doi.org/10.1148/rycan.220019.